Ya-Min Cheng
Papers
1
Total Citations
10
H-Index
1
About
Dr. Ya-Min Cheng is a leading gynecologic oncologist whose research focuses on optimizing treatment strategies for ovarian, tubal, and peritoneal cancers. Her most significant contribution is the landmark ROBOT study, an eight-year real-world investigation that evaluated the long-term efficacy and safety of adding bevacizumab to standard chemotherapy in Asian patients. This work, published in 2020 with 10 citations, provided crucial insights into the prognostic impacts and adverse effects of this targeted therapy in a population often underrepresented in clinical trials. By analyzing consecutive patient records, Dr. Cheng’s research bridges the gap between controlled trial data and everyday clinical practice, offering evidence-based guidance for frontline and relapse treatment. Her dedication to real-world evidence has helped refine therapeutic protocols, improving outcomes for women battling these challenging malignancies. Dr. Cheng’s work stands as a vital resource for clinicians seeking to personalize care and manage treatment-related toxicities effectively.
Research Focus
Key Achievements
Top Papers
- 1